Federal contractor · INDIANAPOLIS, IN

ROCHE DIABETES CARE INC

ROCHE DIABETES CARE INC received $343.1K in federal contract obligations in FY2026, on 3 awards (−52% vs FY2025). Since FY2017: $9M. Its largest customer was Indian Health Service ($343.1K).

Obligations · FY2026
$343.1K
New awards
3
Sole-source
0.0%
Single offer
41%
UEI
F6JDDN8L9JM4
Other than small business

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 853.9KFY2017
  2. 1MFY2018
  3. 893.5KFY2019
  4. 843.6KFY2020
  5. 2MFY2021
  6. 454.1KFY2022
  7. 1.6MFY2023
  8. 264.1KFY2024
  9. 718.1KFY2025
  10. 343.1KFY2026

Top buying agencies

Obligations in FY2026.

  1. 3 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$343.1K100%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition41%
    US 39% · $142K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions41%
    US 8.7% · $142K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. Indian Health Service· Maricopa County, AZ· Health & medical· Aug 28, 2026 – Aug 28, 2026· 75H71226F28008
  2. Indian Health Service· Marion County, IN· Health & medical· Mar 24, 2025 – Feb 10, 2026· 75H71025F80116
  3. Indian Health Service· Maricopa County, AZ· Health & medical· Sep 24, 2021 – Jan 9, 2026· 75H71221F28001

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. QUINCY, MA · 25% of this company's obligations are in markets they both serveIndian Health Service · Pharmaceutical and medicine manufacturing
  2. WICHITA, KS · 25% of this company's obligations are in markets they both serveIndian Health Service · Pharmaceutical and medicine manufacturing
  3. RARE DISEASE THERAPEUTICS, INC.$242.2K+127% in FY2026
    FRANKLIN, TN · 18% of this company's obligations are in markets they both serveIndian Health Service · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.